Systemic delivery of IL-15, a cytokine similar to IL-2, triggers proliferation of NK cells and enhances anti-tumor immunity of CD8 T cells in several preclinical animal model studies (Steel et al., 2012; Yu et al., 2012). Here, CD8A is linked to neoplasm.